Literature DB >> 29623352

Do we need gadolinium-based contrast medium for brain magnetic resonance imaging in children?

Dennis Dünger1, Matthias Krause2, Daniel Gräfe1, Andreas Merkenschlager3, Christian Roth1, Ina Sorge4.   

Abstract

BACKGROUND: Brain imaging is the most common examination in pediatric magnetic resonance imaging (MRI), often combined with the use of a gadolinium-based contrast medium. The application of gadolinium-based contrast medium poses some risk. There is limited evidence of the benefits of contrast medium in pediatric brain imaging.
OBJECTIVE: To assess the diagnostic gain of contrast-enhanced sequences in brain MRI when the unenhanced sequences are normal.
MATERIALS AND METHODS: We retrospectively assessed 6,683 brain MR examinations using contrast medium in children younger than 16 years in the pediatric radiology department of the University Hospital Leipzig to determine whether contrast-enhanced sequences delivered additional, clinically relevant information to pre-contrast sequences. All examinations were executed using a 1.5-T or a 3-T system.
RESULTS: In 8 of 3,003 (95% confidence interval 0.12-0.52%) unenhanced normal brain examinations, a relevant additional finding was detected when contrast medium was administered. Contrast enhancement led to a change in diagnosis in only one of these cases.
CONCLUSION: Children with a normal pre-contrast brain MRI rarely benefit from contrast medium application. Comparing these results to the risks and disadvantages of a routine gadolinium application, there is substantiated numerical evidence for avoiding routine administration of gadolinium in a pre-contrast normal MRI examination.

Entities:  

Keywords:  Brain; Children; Contrast medium; Diagnostic value; Gadolinium; Magnetic resonance imaging

Mesh:

Substances:

Year:  2018        PMID: 29623352     DOI: 10.1007/s00247-017-3999-2

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  25 in total

1.  Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Authors:  Thomas Grobner
Journal:  Nephrol Dial Transplant       Date:  2006-01-23       Impact factor: 5.992

2.  Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent.

Authors:  Alexander Radbruch; Lukas D Weberling; Pascal J Kieslich; Oliver Eidel; Sina Burth; Philipp Kickingereder; Sabine Heiland; Wolfgang Wick; Heinz-Peter Schlemmer; Martin Bendszus
Journal:  Radiology       Date:  2015-04-06       Impact factor: 11.105

3.  Comparison of plain and Gd-DTPA-enhanced MR-imaging in children.

Authors:  P Baierl; A Mühlsteffen; J Haustein; W M Bauer; C Förster; H Fendel; H P Niendorf
Journal:  Pediatr Radiol       Date:  1990

4.  Macrocyclic and Other Non-Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue: Preliminary Results From 9 Patients With Normal Renal Function.

Authors:  Nozomu Murata; Luis F Gonzalez-Cuyar; Kiyoko Murata; Corinne Fligner; Russell Dills; Daniel Hippe; Kenneth R Maravilla
Journal:  Invest Radiol       Date:  2016-07       Impact factor: 6.016

5.  Pediatric Patients Demonstrate Progressive T1-Weighted Hyperintensity in the Dentate Nucleus following Multiple Doses of Gadolinium-Based Contrast Agent.

Authors:  D R Roberts; A R Chatterjee; M Yazdani; B Marebwa; T Brown; H Collins; G Bolles; J M Jenrette; P J Nietert; X Zhu
Journal:  AJNR Am J Neuroradiol       Date:  2016-07-28       Impact factor: 3.825

Review 6.  Gadolinium based contrast agents (GBCA): Safety overview after 3 decades of clinical experience.

Authors:  Emanuel Kanal
Journal:  Magn Reson Imaging       Date:  2016-09-06       Impact factor: 2.546

7.  Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort.

Authors:  Tara Anne Collidge; Peter Campbell Thomson; Patrick Barry Mark; James Phillip Traynor; Alan George Jardine; Scott Thomas William Morris; Keith Simpson; Giles Hannibal Roditi
Journal:  Radiology       Date:  2007-08-17       Impact factor: 11.105

8.  Added utility of gadolinium in the magnetic resonance imaging (MRI) workup of seizures in children younger than 2 years.

Authors:  Myria Petrou; Bradley Foerster; Pavel V Maly; Odd P Eldevik; Steven Leber; Pia C Sundgren
Journal:  J Child Neurol       Date:  2007-02       Impact factor: 1.987

9.  Progressive increase of T1 signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in the pediatric brain exposed to multiple doses of gadolinium contrast.

Authors:  Donna R Roberts; Kenton R Holden
Journal:  Brain Dev       Date:  2015-09-04       Impact factor: 1.961

10.  Extent of Signal Hyperintensity on Unenhanced T1-weighted Brain MR Images after More than 35 Administrations of Linear Gadolinium-based Contrast Agents.

Authors:  Yang Zhang; Yan Cao; George L Shih; Elizabeth M Hecht; Martin R Prince
Journal:  Radiology       Date:  2016-08-11       Impact factor: 11.105

View more
  2 in total

Review 1.  Use and Safety of Gadolinium Based Contrast Agents in Pediatric MR Imaging.

Authors:  Stephanie Holowka; Manohar Shroff; Govind B Chavhan
Journal:  Indian J Pediatr       Date:  2019-02-22       Impact factor: 1.967

2.  Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues?: A Comparative Gadoterate Versus Gadodiamide Study in Juvenile and Adult Rats.

Authors:  Nathalie Fretellier; Agnès Granottier; Marlène Rasschaert; Anne-Laure Grindel; Fannie Baudimont; Philippe Robert; Jean-Marc Idée; Claire Corot
Journal:  Invest Radiol       Date:  2019-02       Impact factor: 6.016

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.